Skip to content

Online Insomnia Treatment in Australian General Practice

Online Cognitive and Behavioural Therapy for Insomnia in Australian General Practice: An Implementation Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619001539123
Enrollment
164
Registered
2019-11-07
Start date
2020-09-25
Completion date
2022-11-15
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Insomnia is a common disorder managed in Australian general practice. Insomnia can be effectively treated with online cognitive and behavioural therapy for insomnia (CBTi), which leads to long-lasting insomnia improvements. We aim to provide Australian GPs with access to an online CBTi program (Sleepio) to treat insomnia and reduce dependence on sleeping pills over time. It is hypothesised that patients referred to this trial of Sleepio will experience improved insomnia symptoms, and reduced sleeping pill use over time.

Interventions

This implementation trial will investigate the feasibility and effectiveness of providing Australian General Practitioners, and general practice patients access to online cognitive and behavioural therapy for insomnia (CBTi), and Royal Australian College of General Practitioner (RACGP) guideline recommendations on 'insomnia' management and 'sleeping pill withdrawal'. We will use existing General Practitioner software to identify three groups of patients, based on recent history of medications c

This implementation trial will investigate the feasibility and effectiveness of providing Australian General Practitioners, and general practice patients access to online cognitive and behavioural therapy for insomnia (CBTi), and Royal Australian College of General Practitioner (RACGP) guideline recommendations on 'insomnia' management and 'sleeping pill withdrawal'. We will use existing General Practitioner software to identify three groups of patients, based on recent history of medications commonly prescribed for insomnia (including; Temazepam, Oxazepam, Nitrazepam, Zolpidem, Zopiclone and Melatonin). We will divide patients into those with; 1. New Insomnia - No history of sleeping pills prescribed in the past 12 months, 2. Single Sleeping Pill Prescription - One sleeping pill prescription in the past 12 months 3. Repeat Sleeping Pill Prescriptions - Two or more sleeping pill prescriptions in the past 12 months Online CBTi will be made available to all three groups of patients. Sleepio (www.sleepio.com, Big Health, UK) is a well-established online CBTi program which includes 6-weekly self-administered sessions. Sleepio includes CBTi components; bedtime restriction therapy, stimulus control therapy, sleep hygiene information, relaxation therapy, and cognitive restructuring techniques. Patients may complete daily sleep diaries (3 min) in addition to weekly CBTi sessions (20-30 minutes each). Patients will receive reminder and summary emails to promote adherence throughout the program, however no additional support will be offered to encourage adherence. Via GP software, treating GPs will be sent notifications containing patient-tailored RACGP insomnia management guidelines and sleeping pill withdrawal information. These GP notifications will differ based on the above patient groups; 1. New Insomnia - GPs will receive a notification containing RACGP guidelines and a referral link to online CBTi, 2. Single Sleeping Pill Prescription - GPs will receive a notification containing RACGP guidelines, printable sleeping pill withdrawal fact sheets and tapering schedules, and a referral link to online CBTi, and 3. Repeat Sleeping Pill Prescriptions - GPs will receive a notification containing RACGP guidelines, printable sleeping pill withdrawal fact sheets and tapering schedules, and a referral link to online CBTi.

Sponsors

The Adelaide Institute for Sleep Health, Flinders University
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

General Practitioner Inclusion Criteria; 1. Currently using the Doctors Control Panel software Patient Inclusion Criteria 1. Age > 18 years. 2. Reliable access to computer, tablet or smartphone, with internet access 3. Basic English language comprehension as required for Sleepio. Group 1 "New Insomnia" - No GP prescriptions of Temazepam, Oxazepam, Nitrazepam, Zolpidem, Zopiclone, or Melatonin in the past 12 months, Group 2 "Single Sleeping Pill Prescription" - One GP prescription of Temazepam, Oxazepam, Nitrazepam, Zolpidem, Zopiclone, or Melatonin in the past 12 months, Group 3 "Repeat Sleeping Pill Prescriptions" - Any combination of two or more GP prescriptions of Temazepam, Oxazepam, Nitrazepam, Zolpidem, Zopiclone, or Melatonin in the past 12 months.

Exclusion criteria

Patient Exclusion Criteria (assessed by treating GPs, according to RACGP/Sleepio recommendations); 1. Drug or alcohol problems 2. Terminal illness 3. Acute crisis 4. Risk of suicide 5. Severe mental illness 6. Organic brain disease 7. Epilepsy requiring benzodiazepine as part of anticonvulsant therapy 8. Benzodiazepine prescriptions for muscle spasms 9. Women who are currently pregnant Patient Exclusion Criteria (Assessed via online self-reported screening questionnaire): 1. Any previous diagnosis of Obstructive Sleep Apnea, Restless Legs Syndrome, or REM Behaviour Disorder.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 22, 2026